1. 216. A Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of the Beta-lactamase inhibitor Xeruborbactam Alone and in Combination Meropenem in Healthy Adult Subjects. (15th December 2022) Authors: Griffith, David; Roberts, Jason; Wallis, Steven; Hernandez-Mitre, Maria Patricia; Morgan, Elizabeth; Gehrke, Shawnee; Dudley, Michael; Loutit, Jeff Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 217. A Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of the Lipopeptide QPX9003 in Healthy Adult Subjects. (15th December 2022) Authors: Griffith, David; Carmeli, Yehuda; Gehrke, Shawnee; Morgan, Elizabeth; Dudley, Michael; Loutit, Jeff Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗